Effect of mammography on older women’s life expectancy still unclear.
It is still unknown if regular screening mammography would benefit women aged 65 and older, according to a study published in the Journal of General Internal Medicine.
Researchers from the University of California, San Francisco; the San Francisco VA Medical Center; and the University of California, Berkeley, conducted a systematic review to assess the quality and limitations of published studies examining benefits and harms of screening mammography in relation to comorbidity and age.
The researchers reviewed studies published between January 1980 and June 2013 that examined the benefits or harms of screening mammography among older women, in relation to comorbidity. Using data regarding setting, design, quality, screening schedule, measure of comorbidity, and estimates of benefits and/or harms, they identified seven articles out of 1,760 titles that met their criteria:[[{"type":"media","view_mode":"media_crop","fid":"46123","attributes":{"alt":"mammography","class":"media-image media-image-right","id":"media_crop_5346761876178","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5332","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 120px; width: 180px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©zlikovec/Shutterstock.com","typeof":"foaf:Image"}}]]
• Two prospective cohort studies
• Two retrospective cohort studies
• Three decision analyses studies
The researchers did not identify any suitable randomized controlled trials.
The results found that four studies examined at least one measure of life expectancy or reduction in the risk of breast cancer death as a marker of benefit and three studies addressed the harms of screening mammography, including false-positive results. “Both cohort studies and decision analyses showed that screening benefits decreased with increasing age and comorbidity burden,” the authors wrote.
There is still limited evidence that suggest that women over the age of 65 without severe comorbidity would see any improvements to life expectancy as a result of routine mammography screening. “Given the potential for harm, it is unclear whether the magnitude of the benefit is sufficient to warrant regular screening,” the authors concluded. “Women, clinicians and policymakers should consider these factors in deciding whether continue screening.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.